Radiology workflow software company Sirona Medical has received $42 million in Series C financing, bringing total investment raised to $100 million. The company also named a new CEO.
Avidity Partners, a participant in the previously announced Series B financing, led this round with additional participation from other existing investors, including 8VC, and GreatPoint Ventures.
San Francisco-based Sirona said its Unify platform unifies diagnostic and clinical image viewing, radiology reporting, worklist, and AI (including impression generation) on a single cloud-native platform.
The Unify platform can be deployed as an overlay to existing on-premises systems (PACS and RIS), allowing radiology practices that service multiple hospitals and health systems to combine disparate workflows into a single unified workflow experience.
The new capital will support commercial expansion as well as the continued evolution of the Unify platform, particularly around workflow efficiency and AI-powered report generation.
Hooman Hakami, who has served as a senior executive at GE Healthcare and Medtronic, has been appointed CEO. Cameron Andrews, Sirona’s founder, will remain involved in his new role as president.
“We are entering the next phase in the company’s maturity and ability to deliver our next-generation solution to a broader audience while supporting the success of every customer,” said Andrews, in a statement.
“The Sirona vision is compelling. Cameron and the entire team have done an excellent job achieving a level of workflow integration across multiple platforms that no other company has reached in radiology IT. I look forward to working alongside Cameron and the entire Sirona team as we enter this new growth phase,” said Hakami in a statement.
Sirona Medical is led by a team of software engineers, data scientists, and radiology professionals including Alan Kaye, M.D., chief medical officer and former president of the American College of Radiology (ACR), as well as industry veterans from Sectra, Arterys, R2 Technologies, and others. Notable advisors include Curt Langlotz, M.D., Ph.D., director at the Center for Artificial Intelligence in Medicine and Imaging (AIMI) at Stanford University; Chris Wood, former CTO at Intelerad; Ron Paulus, former CEO at Mission Health, and; Bob Baumgartner, retired executive chairman of the board at the Center for Diagnostic Imaging.
